7[1] Espersen GT, Mathiesen O, Grunnet N, Jensen S et al. Cytokine plasma levels and lymphocyte subsets in patient withnewly diagnosed insulin-dependent (type 1)diabetes mellitus before and following initial insulin treatment[J]. APMIS, 1997; 101(6):703-706.
8[2] Thomas MP, Hemming P, Jens M et al. Monokine antagonism is reduced in patients with IDDM[J]. Diabetes, 1994； 43（10）:1242-1247.
9[3] Molvig， Bak L，Christensen P et al. Endotoxin-stimulated human monocyte secretion of interleukin-1, tumur necrosis factor alpha, and prostaglandin E2 shows stable interindividual difference[J]. Scand J Immunol, 1988; 27（6）:705-716.
10[4] Harrsion LC, Honeyman MC, De Aizpurua HJ et al. Inverse relation between humoral and cellular immunity to glutamic acid decarboxylase in subject at risk of insulin-dependent diabetes[J]. Lancet, 1993; 341（5）:1365-1369.
7BERKOWITZ B A, BISSIG D, DUTCZAK O, et al. MRI bio- markers [or evaluation of treatment e{ficacy in preclinieal dia- betic retinopathy[J]. Expert Opin Med Diagn, 2013,7(4): 393-403.
8BYON I S, JEON H S, KIM H W, et al. The effect of a sys temic angiotensin receptor blocker on vascular endothelial growth factor in the vitreous of patients with proliferative dia- betic retinopathy[J]. Curt Eye Res, 2013,38(7)774-780.
